Artificial intelligence analysis of advanced breast cancer patients from a phase I trial of trastuzumab deruxtecan (T-DxD): HER2 and histopathology features as predictors of clinical benefit Meeting Abstract
| Authors: | Modi, S.; Glass, B.; Prakash, A.; Taylor-Weiner, A.; Elliott, H.; Wapinski, I.; Sugihara, M.; Saito, K.; Kerner, J. K.; Phillips, R.; Shibutani, T.; Honda, K.; Khosla, A.; Beck, A. H.; Cogswell, J. |
| Abstract Title: | Artificial intelligence analysis of advanced breast cancer patients from a phase I trial of trastuzumab deruxtecan (T-DxD): HER2 and histopathology features as predictors of clinical benefit |
| Meeting Title: | ESMO Virtual Congress 2020 |
| Journal Title: | Annals of Oncology |
| Volume: | 31 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2020 Sep 19-21/Oct 16-18 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2020-09-01 |
| Start Page: | S355 |
| End Page: | S356 |
| Language: | English |
| ACCESSION: | WOS:000573469100286 |
| DOI: | 10.1016/j.annonc.2020.08.388 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 286P -- Source: Wos |
